Tumor markers for renal cell carcinoma

Journal of Urology

Volumn 173, Issue 6, 2005, Pages 1847-

  Oosterwijk, E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BAY 9006; CD70 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROSTAGLANDIN E2; SUNITINIB; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CLEAR CELL CARCINOMA; EDITORIAL; GENE MUTATION; KIDNEY CARCINOMA; PRIORITY JOURNAL; SOLID TUMOR;

EID: 18744391103     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000163779.65884.6c     Document Type: Editorial

References (4)

1. Locksley, R. M., Killeen, N. and Lenardo, M. J.: The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell, 104: 487, 2001
2. Uemura, H., Nakagawa, Y., Yoshida, K., Saga, S., Yoshikawa, K, Hirao, Y. et al: MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br J Cancer, 81: 741, 1999
3. Grabmaier, K. A., de Weijert, M. C., Verhaegh, G. W., Schalken, J. A. and Oosterwijk, E.: Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma. Oncogene, 23: 5624, 2004
4. Smyth, G. P., Stapleton, P. P., Barden, C. B., Mestre, J. R., Freeman, T. A. et al: Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells. Ann Surg Oncol, 10: 455, 2003